Morphine alters the immune response to influenza virus infection in Lewis rats

Advances in Experimental Medicine and Biology

Volumn 437, Issue , 1998, Pages 73-82

  Coussons Read, Mary E ^a   Daniels, Mary ^b   Gilmour, Matthew Ian ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION SENSITIVITY; INFLAMMATION; INFLUENZA VIRUS; LUNG INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS INFECTION;

ANIMALIA; INFLUENZA VIRUS;

EID: 0031854397     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5347-2_9     Document Type: Conference Paper

References (21)

1. Brown, B. Stimmell, R.N. Taub, S. Kochwa, and R.E. Rosenfield, Immunologic dysfunction in heroin addicts, Arch. Int. Med, 134:1001 (1974).
2. R.M. Donahoe, J.J. Madden, F. Hollingworth, D. Shafer, and A. Falek, Morphine depression of T-cell E-rossetting: Definition of the process, Proc. Am. Soc. Exp. Biol., 44:95 (1985).
3. R.J. McDonough, J.J. Madden, A. Falek, D.A. Shafer, M. Pline, D. Gordon., P. Bokos, J.C. Kuelmie, and J. Mendelson, Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: In vivo evidence for opiate receptor sites on T lymphocytes, J. Immunol., 125:2539 (1980).
4. R.M. Donahoe, C. Buesos-Ramos, F. Donahoe, J.J. Madden, and A. Falek, Mechanistic implications of the finding that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers, Ann. New York Acad. Sci., 496:711 (1987).
5. H.U. Bryant, E.W. Bernton, and J.W. Holaday, Immunosuppressive effects of chronic morphine treatment in mice, Life Sci., 41:1731 (1987).
6. H.U. Bryant, E.W. Berton, and J.W. Holaday, Morphine pellet-induced immunomodulation in mice: Temporal relationships, J. Pharm. Exp. Ther., 245:913 (1988).
7. R.J. Weber, B. Ikejiri, K.C. Rice, A. Pert, and A.A. Hagan, Opiate receptor mediated regulation of the immune response in vivo, in Problems of Drug Dependence, L.S. Harris. Ed., NIDA Res. Monogr., 76:341 (1987).
8. Y. Shavit, J.W. Lewis, G.W. Terman, R.P. Gale, and J.C. Liebeskind, Opioid peptides mediate the suppressive effect of stress on natural-killer cell cytotoxicity, Science, 223:188 (1984).
9. S.S. Lefkowitz and C.Y. Chiang, Effects of certain abused drugs on hemolysin forming cells, Life Sci., 17:1763 (1975).
10. E. Tubaro, G. Borelli, C. Croce, G. Cavallo, and C. Santiangeli, Effect of morphine on resistance to infection, J. Infect. Dis., 148:656 (1983).
11. D.T. Lysle, M.E. Coussons, V.J. Watts, E.H. Bennett, and L.A. Dykstra, Morphine-induced alterations of immune status: Dose-dependency, compartment specificity, and antagonism by naltrexone, J. Pharm. Exp. Then, 265:1071 (1993).
12. B.M. Bayer, S. Daussin, M. Hernandez, and L. Irvin, Morphine inhibition of lymphocyte activity is mediated by and opioid-dependent mechanism, Neuropharm., 29:369 (1990).
13. J.P. Ehrlich and G.R. Burleson, Enhanced and prolonged pulmonary influenza virus infection following phosgene inhalation, J. Toxicol. and Environ. Health, 34:259 (1991).
14. K. Gylires, I. Budavari, S. Furst, and I. Molnar. Morphine inhibits the carrageenan-induced oedema and the chemoluminescence of leucocytes stimulated by zymosan, J. Pharm. Pharmacol., 37:100 (1985).
15. P. Sacerdote, M. Bianchi, and A.E. Panerai, Involvement of B-endorphin in the modulation of paw inflammatory edema in the rat, Reg. Peptides, 63:79 (1996).
16. D. H. Broide, Inflammatory Cells: Structure and Function, in Basic and Clinical Immunology, D.P, Stiles and A.I. Terr Eds., Appleton and Lange, Norwalk (1991).
17. R.J. Weber and A. Pert, The periaqueductal grey matter mediates opiate-induced immunosuppression, Science, 245:188 (1989).
18. P.J. Cabot, T. Crammond, and M.T. Smith, Quantitiative autoradiography of peripheral opioid binding sites in rat lung, Euro. J. Pharm., 310:47 (1996).
19. P.J. Cabot, P.R. Dodd, T. Crammond, and M.T. Smith, Characterization of non-conventional opioid binding sites in rat and human lung. Euro. J. Pharm., 268:247 (1994).
20. H. Lebrec, K. Sarlo, and G.R. Burleson, Effect of influenza virus infection on ovalbumin-specific IgE responses to inhaled antigen in the rat, J. Toxicol. Environ. Health, 49: 619 (1996)
21. J.P. Ehrlich, A.F. Gunnison, and G. R. Burleson, Influenza virus-specific cytotoxic T-lymphocyte activity in Fischer 344 rat lungs as a method to assess pulmonary immunocompetence: Effect of phosgene inhalation, Inhal. Toxicol., 1:129 (1989).